Are there any issues with a high protein diet in patients with Waldenström's macroglobulinemia (WM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

There are no specific contraindications to a high protein diet for patients with Waldenstrom macroglobulinemia (WM), but some considerations are warranted, particularly for those with kidney complications or hyperviscosity syndrome, as noted in recent studies 1, 2. Patients with WM can generally follow a balanced diet that includes adequate protein, but should consult with their hematologist or oncologist before making significant dietary changes. For those with WM who have developed kidney complications, protein intake may need to be monitored more carefully, as excessive protein could potentially stress compromised kidneys. Additionally, some WM patients experience hyperviscosity syndrome, where the blood becomes thicker due to high levels of IgM protein; in these cases, staying well-hydrated is particularly important when consuming a high-protein diet. Some key points to consider include:

  • The potential for kidney complications, which may require monitoring of protein intake 1
  • The risk of hyperviscosity syndrome, which can be managed with plasmapheresis and other treatments 3, 4, 2
  • The importance of personalized guidance and regular monitoring of kidney function, blood viscosity, and overall nutritional status 1, 2 It is essential to prioritize the individual patient's needs and complications when considering dietary changes, rather than making general recommendations for all WM patients. The most recent and highest quality study 2 supports the efficacy and safety of plasmapheresis followed by primary therapy for WM with hyperviscosity syndrome, highlighting the importance of tailored treatment approaches.

References

Research

Efficacy and safety of therapeutic procedure for Waldenström's macroglobulinemia with hyperviscosity syndrome.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.